Halaven 0.5mg Injection: Anticancer Treatment

Description:

• Contains the active substance eribulin.
• Belongs to the class of antineoplastic agents.
• Used in adults for advanced breast cancer or liposarcoma when other treatments have stopped working.

Uses:

• Advanced breast cancer.
• Liposarcoma.

Therapeutic Effects:

• Stops the growth and spread of cancer cells.
• Specifically targets the growth phase of microtubules.
• Prevents cell division without interfering with the shrinking phase.
• Causes tubulin to clump together, disrupting cell division.
• Leads to the blockage of the cell cycle (G2/M phase) and triggers cell death through apoptosis.

Interaction with Other Drugs:

• Inform your doctor about all the medicines you take.
• Certain medications may interact with Halaven 0.5mg Injection and reduce effectiveness.

Storage:

• Store Halaven 0.5mg Injection in the refrigerator between 25°C.
• Keep it in its original packaging.
• Protect it from light and moisture.
• Keep it out of the reach of children and pets.

How to Consume:

• Given by your healthcare provider through an intravenous infusion.
• Dose, duration, and frequency determined by your healthcare provider based on age, body weight, and severity of condition.
• Do not miss or delay doses without consulting your healthcare provider.
• Do not stop treatment without physician advice.

Safety Advice:

• Pregnancy: unsafe for pregnant women as it may cause fetal harm.
• Breastfeeding: not recommended while breastfeeding.
• Lungs: can cause side effects like blood clots in the lungs and inflammation of the lungs.
• Liver: can affect the liver's normal functioning.
• Alcohol: avoid or limit alcohol intake.
• Driving: causes tiredness and dizziness, which may impair your ability to drive, cycle, or operate machinery.

Side Effects:

• Serious: sepsis (severe infection), severe allergic reaction, serious skin conditions (Stevens-Johnson syndrome).
• Common: decrease in the number of white blood cells or red blood cells, tiredness or weakness, nausea, vomiting, constipation, diarrhea, numbness, tingling or prickling sensations, fever, loss of appetite, weight loss, difficulty breathing, cough, pain in the joints, muscles, and back, headache, hair loss.

Word of Advice:

• Your doctor will monitor your liver function via blood tests and assess your heart function before and during treatment.
• Ensure reliable birth control while taking Halaven 0.5mg Injection and for at least three months after stopping it.
• Consult your doctor for guidance on alternative contraception methods.
• Talk to your oncologist if you need dental treatment.
• Always tell your dentist you are having cancer treatment.
• This treatment can affect fertility in men and women.

FAQs:

1. What is the most important information I should know while taking Halaven 0.5mg Injection?

   • Halaven 0.5mg Injection can cause serious adverse effects such as low white blood cell count, numbness, tingling, and pain in the hands and feet. Inform your physician immediately if you face any of these symptoms.

2. Does Halaven 0.5mg Injection cause infertility?

   • Yes, Halaven 0.5mg Injection causes infertility in men and women. It is necessary to use effective birth control methods during the treatment and for three weeks (females) and 14 weeks (males) after the final dose of the injection.

3. Is hair loss caused by Halaven 0.5mg Injection reversible?

   • Hair loss is a common side effect of Halaven 0.5mg Injection. It is reversible, but it depends totally on the severity of the hair loss and varies from person to person. Consult your doctor if you have severe hair loss.

4. Do I have to follow any special dietary requirements while taking Halaven 0.5mg Injection?

   • It depends upon the severity of the disease condition. You can have a normal diet until your physician tells you to follow any special food or diet chart. Check with your doctor if you have any nutrition concerns.

5. What should I do if I miss taking Halaven 0.5mg Injection?

   • It is important to get the injection at the right time. If you missed your appointment, contact your healthcare provider and schedule your dosing immediately. Keep follow-ups on your next schedule.

Fact Box:

• Molecule name: Eribulin.
• Therapeutic class: Anticancer.
• Pharmacological class: Monoclonal antibody-drug conjugate.
• Indications: Advanced breast cancer, liposarcoma.
• Dosage form: Injections.
• Habit forming: No.

Tags: cancer_treatment, chemotherapy, halaven, injections, oncology, medication